Philidor

Shares of Valeant Pharmaceuticals Intl Inc (NYSE: VRX) were down more than 25 percent following reports from Citron Research and SIRF that the company is engaged in questionable sales and accounting practices. The crux of Citron Research's short thesis is that R&O Pharmacy, which filed...

Shares of Valeant Pharmaceuticals Intl Inc (NYSE: VRX) plummeted 40 percent on Wednesday after noted short-seller Citron Research referred to the company as the "pharmaceutical Enron." Citron's report said it has published a "smoking gun" detailing what it calls a "cover up" concerning Valeant's...